Propel

Amprion is a biotechnology company based in San Francisco, California, established in 2007. The firm specializes in the diagnosis of neurodegenerative diseases, particularly focusing on conditions such as Parkinson’s disease, Alzheimer’s disease, and Lewy Body Dementia. Amprion develops innovative early detection technologies aimed at improving understanding of brain health. By leveraging personal biometrics and collective knowledge, the company seeks to enhance the ability of researchers and healthcare professionals to identify and understand these brain diseases, ultimately contributing to better patient outcomes and advancing the field of neuroscience.

Healx, established in 2014 and headquartered in Cambridge, UK, is a biotechnology company specializing in rare disease treatments. It employs artificial intelligence and machine learning to identify and repurpose existing drugs for new therapeutic uses, aiming to accelerate drug discovery and reduce development risks. By integrating AI, deep pharmacology expertise, and patient engagement, Healx matches treatments to disease patients, addressing unmet needs in rare diseases.

Motion Gestures is a Canadian startup founded in 2016 in Waterloo, specializing in machine learning-based gesture recognition software. The company focuses on developing technology that enables the rapid creation of gesture-enabled interfaces for various systems, devices, and applications. Its software supports advanced 2D and 3D gesture recognition utilizing motion, touch, and vision sensors. This technology can be deployed across different platforms, including cloud, gateway, and embedded systems, allowing for quick integration without the need for extensive programming or data input. Motion Gestures provides developers with free licenses to its cloud SDK, facilitating the swift creation and testing of gestures using smartphones.

SafeTraces is a leading provider of sustainable indoor air quality solutions, specializing in the verification of ventilation and filtration performance in indoor environments. The company offers a unique platform that actively measures pathogen risk, ensuring safer breathing conditions for occupants. By utilizing real-world data, SafeTraces enhances public trust and confidence in building safety, making it a critical resource for those concerned about indoor air quality. Its solutions are backed by the first UL mark for verified ventilation and filtration, demonstrating a commitment to safety and environmental monitoring.

Nextnet is a Silicon Valley-based startup focused on utilizing Generative AI technology to enhance biomedical research. The company operates a cloud-based platform designed to assist scientists in uncovering hidden connections within biomedical data. By creating a semantic web that organizes, integrates, and contextualizes extensive biomedical knowledge, Nextnet aims to make this information readily accessible to professionals in the biotech sector. Its primary offering is a Generative AI-powered knowledge browser, which allows knowledge workers to engage with complex life science queries using simple natural language. This innovative approach facilitates the generation of objective hypotheses and supports collaborative decision-making among scientists.

Repurpose, Inc., established in 2011 and headquartered in Los Angeles, California, specializes in the development, manufacturing, and distribution of plant-based, compostable tableware. Their product range includes plates, cups, bowls, and utensils, sold both online and through retail stores across the United States. Repurpose's mission is to provide eco-friendly alternatives to petroleum-based disposable plasticware, contributing to a cleaner environment and promoting sustainable practices among consumers and businesses.

TaskHuman, Inc. operates an online platform that facilitates video coaching aimed at enhancing personal wellness. Founded in 2017 and based in Palo Alto, California, the platform connects users with a diverse network of coaches, including athletic trainers, life coaches, nutrition experts, yoga instructors, and specialists across various wellness domains. TaskHuman allows individuals to engage in real-time, one-on-one interactive sessions through video calls, addressing over 1,000 aspects of well-being, such as physical fitness, mental health, spiritual growth, and career development. The company aims to make self-care and personal wellness accessible and affordable, empowering users to improve their health and lifestyle through personalized coaching.

Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.

Brelyon, Inc. is a technology company based in Redwood City, California, founded in 2019. The company specializes in manufacturing headset-free virtual display screens that serve as an alternative to traditional multi-monitor setups and virtual reality headgear. Brelyon's innovative displays utilize proprietary depth modulation and light-field expansion technologies to deliver immersive experiences, allowing users to view expansive virtual screens with true optical depth. Their products are designed for various applications, including office environments, gaming, and teleoperations, and aim to enhance user interaction in both enterprise and metaverse contexts. Brelyon is positioned as a pioneer in developing solutions that eliminate the need for headsets, offering a unique viewing experience akin to looking through a large IMAX screen.

BlockApps, Inc. is a blockchain technology company founded in 2015 and based in Brooklyn, New York. It specializes in the development of the BlockApps STRATO platform, which allows enterprises to build, deploy, and manage Ethereum-based blockchain applications. STRATO supports the creation of hybrid private, consortium, and public blockchains, providing a comprehensive solution for various industries, including software startups, IT firms, and Fortune 500 companies. In addition to its core platform, BlockApps has introduced the STRATO Mercata Blockchain Protocol and Marketplace, facilitating the digital ownership of assets like whiskey casks, precious metals, carbon offsets, and collectibles through a network of verified partners. With a focus on enhancing data visibility, automating processes, and reducing reliance on intermediaries, BlockApps aims to enable secure and efficient decentralized application management. The company has garnered approximately $50 million in investments and has established strategic partnerships to further its mission.

Rellevate, LLC is a financial services company based in Stamford, Connecticut, established in 2019. It specializes in digital banking services designed to enhance consumer financial management. Rellevate offers a range of products, including digital accounts that earn interest, as well as features like Pay Any-Day, bill payment, and money transfer services. These offerings are primarily delivered through employers, aiming to improve employee retention, satisfaction, and loyalty. By allowing users to access, move, and utilize their money anytime and anywhere, Rellevate empowers consumers to take greater control of their finances and fosters a more adaptable financial ecosystem.

Serinus Labs, Inc. is a manufacturer of nano-scale silicon gas sensors, established in 2017 and located in Berkeley, California. The company specializes in developing integrated chip-scale gas sensors tailored for various industries, including health and safety, automotive, consumer electronics, and healthcare. Serinus Labs offers custom solutions for both established and emerging gas sensor markets, focusing on applications such as Li-ion battery state-of-health monitoring. Their ultra-low-power trace gas sensors contribute to enhancing battery intelligence, particularly in electric vehicles, addressing critical needs in strategic markets.

Sensulin, LLC is an Oklahoma-based company that focuses on developing glucose-responsive insulin for the treatment of type I and type II diabetes. Utilizing its proprietary Agglomerated Vesicle Technology, the company creates a drug delivery platform that employs liposomes linked by a stimulus-responsive molecule. This innovative approach aims to mimic the functionality of a healthy human pancreas, potentially allowing for a true once-a-day insulin solution. Sensulin's insulin formulation seeks to eliminate the necessity for separate basal and prandial insulin, significantly reducing the need for glucose monitoring and multiple daily injections, thereby improving the quality of life for individuals living with diabetes. Established in 2011, Sensulin is dedicated to advancing diabetes care through its groundbreaking research and development efforts.

Connect Homes specializes in the development of affordable, high-modern prefabricated residential homes. Drawing from a decade of research, the company offers low-cost modular homes that reflect the aesthetic qualities of mid-century modern California architecture. Each home is manufactured in their San Bernardino factory, arriving 95% complete with all necessary finishes, appliances, and systems installed. This allows for quick installation and move-in readiness within a few weeks. The homes can be shipped globally using the intermodal shipping container network, making them adaptable to various environments and customer preferences. By utilizing a modular system, Connect Homes aims to make modern living accessible to a broader audience.

Varo Money, Inc. is a digital bank based in San Francisco, California, that offers a range of online banking products and services, including bank and savings accounts, checking accounts, and overdraft protection. Established in 2015 and known for being the only U.S. consumer fintech with a national bank charter, Varo aims to serve as a comprehensive banking partner for millions of Americans, especially those seeking better financial solutions. The company combines fintech innovation with the security of a chartered bank, providing tools and insights to enhance financial resilience for its customers. Varo's platform also includes features such as spending analysis, real-time budgeting, cash flow forecasts, direct deposits, and online bill payments, all designed to empower users to make informed financial decisions and improve their overall financial well-being.

Hayden AI focuses on developing artificial intelligence and machine learning technologies aimed at enhancing urban mobility and safety. The company specializes in automated enforcement solutions for dedicated bus lanes and bus stops, which are designed to expedite public transit and improve the overall quality of life in urban areas. By leveraging advanced technology and a network of mobile devices, Hayden AI works to create safer and smarter cities. Its platform enables clients to utilize AI-powered tools that can detect and analyze traffic incidents, contributing to more efficient traffic management and fostering a sustainable urban environment.

Stingray Therapeutics is a biotech company based in Houston, Texas, founded in 2018. The company specializes in developing innovative immunotherapies aimed at treating various forms of cancer. Its approach includes the creation of oral medications that stimulate innate immunity modulators within interferon gene pathways. These therapies feature potent and selective small molecule inhibitors designed to enhance the immune system's ability to combat cancer effectively. By integrating these mechanisms, Stingray Therapeutics aims to provide clinicians with advanced tools to improve cancer treatment outcomes.

Syntr Health Technologies, founded in 2019 by Ahmed Zobi, Hugo Salas, and Justin Stovner, is a start-up based in Irvine, California. The company specializes in the development and testing of the SyntrFuge™, a medical device designed for the micro fragmentation of adipose tissue. This device allows healthcare providers to process autologous adipose tissue harvested through existing liposuction systems directly at the point of care. The SyntrFuge™ aims to address various age-related medical conditions, including reducing diabetic amputations, treating diabetic foot ulcers, combating facial fat loss, and alleviating knee osteoarthritis.

Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

Liatris specializes in the development and manufacturing of innovative insulation products aimed at enhancing energy efficiency for both businesses and individuals. Their offerings are made from naturally occurring materials such as asbestos, cork, cotton, and wool, ensuring that they are environmentally safe, non-flammable, and non-toxic. Liatris’ products are designed to meet the growing demand for fire-resistant insulation while providing significant energy savings compared to traditional materials. These performance improvements not only contribute to cost reductions in the construction sector but also facilitate easier installation, making them a practical choice for engineers and builders seeking to optimize thermal energy management.

TrueAlgae is a biotechnology company focused on harnessing the benefits of microalgae for various industries. By utilizing a proprietary closed-loop modular system, the company produces microalgae and its byproducts, which are rich in macro and micronutrients. These products are applicable in food, feed, agriculture, and cosmetics, providing clients with sustainable resources for diverse commercial uses. TrueAlgae aims to promote natural, regenerative, and sustainable practices through its innovative approach to microalgae cultivation.

Weav3D Inc. develops and commercializes advanced composite forming technology originally created at the Georgia Institute of Technology. Established in 2017 and based in Norcross, Georgia, the company specializes in automated processes that integrate weaving with composite consolidation. This innovative approach significantly reduces waste, cycle time, and material handling costs. Weav3D's manufacturing capabilities include continuous lamination, D-LFT compression molding, and injection molding, allowing for the production of lightweight structural composite parts. The technology enables businesses to fabricate optimized lattice structures and offers a cost reduction of up to 75% compared to traditional carbon fiber composites, making it particularly suitable for high-volume and cost-sensitive applications.

InnaMed, Inc. is a Philadelphia-based company that specializes in developing an at-home blood testing device combined with remote monitoring software. Founded in 2016, InnaMed's innovative solutions allow patients to conduct blood tests that quantify established biomarkers, complete condition-specific symptom surveys, and report vital signs such as blood pressure, heart rate, and weight from the comfort of their homes. Utilizing patented DNA-driven assay technology, aptamer reagents, and advanced signal processing hardware, InnaMed provides rapid and reliable test results, facilitating early detection of illnesses through cloud-based health analytics. This approach aims to empower patients by offering convenient access to important health assessments without the need for in-person visits.

Zenflow, Inc. is a medical device company based in San Francisco, California, that specializes in providing innovative solutions for men suffering from benign prostatic hyperplasia (BPH) symptoms. Founded in 2014 by a team of Stanford University Biodesign Fellows in collaboration with leading urologists, the company aims to address the significant unmet clinical need for effective urinary obstruction treatments. Zenflow's primary product is a spring-like device designed to gently prop open the urethra, restoring its normal function without damaging surrounding tissues. This approach prioritizes patient comfort and minimizes invasiveness, offering a less painful alternative to traditional treatments for urinary obstruction caused by an enlarged prostate.

Rellevate, LLC is a financial services company based in Stamford, Connecticut, established in 2019. It specializes in digital banking services designed to enhance consumer financial management. Rellevate offers a range of products, including digital accounts that earn interest, as well as features like Pay Any-Day, bill payment, and money transfer services. These offerings are primarily delivered through employers, aiming to improve employee retention, satisfaction, and loyalty. By allowing users to access, move, and utilize their money anytime and anywhere, Rellevate empowers consumers to take greater control of their finances and fosters a more adaptable financial ecosystem.

Bambu is a prominent digital wealth technology provider that focuses on developing and marketing digital wealth solutions for financial institutions. Founded in 2016 and headquartered in Singapore, the company offers its products under the brand names Intelligent Advisor, White-Label Robo, and Portfolio Builder. Bambu's cloud-based platform utilizes proprietary algorithms and machine learning tools to simplify saving and investing for clients. The company caters to various sectors, including banking, family offices, insurance, and asset management, serving over 20 financial institutions globally. In addition to its Singapore headquarters, Bambu has a subsidiary in the United Kingdom and the United States, along with representatives in the EMEA region. By leveraging advanced technology, Bambu enables its clients to provide personalized investment advice and create tailored portfolios for their customers.

Motion Gestures is a Canadian startup founded in 2016 in Waterloo, specializing in machine learning-based gesture recognition software. The company focuses on developing technology that enables the rapid creation of gesture-enabled interfaces for various systems, devices, and applications. Its software supports advanced 2D and 3D gesture recognition utilizing motion, touch, and vision sensors. This technology can be deployed across different platforms, including cloud, gateway, and embedded systems, allowing for quick integration without the need for extensive programming or data input. Motion Gestures provides developers with free licenses to its cloud SDK, facilitating the swift creation and testing of gestures using smartphones.

Cage Bio is a clinical-stage company based in San Carlos, California, focused on developing innovative topical products for dermatology, inflammation, and immunology. By utilizing its proprietary deep eutectic ionic liquid platform, the company aims to provide effective localized treatments that reduce the need for systemic medications and their associated side effects. The technology harnesses the antimicrobial and anti-inflammatory properties of ionic liquids, enhancing solubility and permeability to improve the efficacy of treatments for various dermal conditions.

Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, specializing in the development of therapeutics that target bone-related diseases. The company utilizes a unique prodrug platform that delivers bi-specific small-molecule therapeutics selectively to bone tissue, minimizing side effects associated with systemic exposure. Its lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic, designed to potentially reverse bone loss linked to conditions such as Duchenne muscular dystrophy and osteoporosis. Mesentech's proprietary technology overcomes the challenges of delivering medications to the difficult-to-treat bone environment, which often requires high drug doses and can lead to significant side effects. Through pre-clinical in-vivo models, the effectiveness of this bone-targeting system has been confirmed, positioning Mesentech to address various low-bone-density disorders and enhance bone healing outcomes. The company was incorporated in 2013 and continues to innovate in the field of bone therapeutics.

Cover Financial, Inc. is a mobile-first insurance brokerage that offers a range of insurance products, including coverage for commercial property, workers compensation, general liability, and cyber risks. The company, founded in 2015 and headquartered in San Francisco, California, operates a mobile application that simplifies the insurance process. Users can take a picture of the item they wish to insure, whether it be vehicles, mobile phones, pets, or homes, and the app connects them with various insurance partners to find competitive rates and suitable coverage options. This innovative approach allows users to efficiently compare policies and select the best fit for their needs.

WRM Software develops business productivity applications aimed at enhancing operational efficiency and improving business processes. The company's offerings include specialized tools such as the storm manager and ops manager applications, which facilitate seamless connectivity between field and office operations. These applications are designed to be user-friendly, ensuring that all team members have access to the latest information at any time. WRM Software's solutions support emergency response operations and field service management, helping organizations streamline their management processes.

Aperio Systems, Inc. specializes in cybersecurity and operational resilience for industrial control systems. Founded in 2020 and headquartered in Boston, Massachusetts, with an additional office in Caesarea, Israel, the company offers proprietary technology that protects against data forgery by detecting artificial manipulation of industrial process data in real-time. This capability ensures accurate monitoring and swift remediation of issues without disrupting operations. Aperio's DataWise platform further enhances data integrity by automatically validating operational data at scale, improving accuracy and security. By providing reliable data, Aperio enables organizations across various sectors to make informed decisions, thereby supporting their profitability and sustainability objectives while effectively managing risks in their industrial operations.

TeselaGen Biotechnology, established in 2011 and headquartered in San Francisco, specializes in DNA design and assembly tools for biological research. The company provides a cloud-based solution enabling combinatorial gene design and editing, which includes tools for visualizing, editing, and annotating genetic sequences, constructing novel gene constructs, optimizing assembly protocols, and validating design variants.

LARQ, Inc. is a company based in Foster City, California, founded in 2017. It specializes in the manufacture and sale of self-cleaning water bottles and purification systems. LARQ's innovative bottles utilize ultraviolet-C LED technology to eliminate bio-contaminants, including germs, bacteria, and protozoa, ensuring safe drinking water for users wherever they are. The company emphasizes both sustainability and design in its products, which are sold primarily through online channels.

Decent Inc. is a company that specializes in providing health and medical insurance plans tailored for self-employed professionals. Founded in 2018 and based in Mill Valley, California, Decent offers plans such as the Trailblazer Plan, which is designed to meet the comprehensive health needs of freelance workers. The company focuses on delivering more affordable healthcare by aligning incentives that promote better health outcomes, reduce overall costs, and prioritize the needs of its members in the healthcare process.

Brelyon, Inc. is a technology company based in Redwood City, California, founded in 2019. The company specializes in manufacturing headset-free virtual display screens that serve as an alternative to traditional multi-monitor setups and virtual reality headgear. Brelyon's innovative displays utilize proprietary depth modulation and light-field expansion technologies to deliver immersive experiences, allowing users to view expansive virtual screens with true optical depth. Their products are designed for various applications, including office environments, gaming, and teleoperations, and aim to enhance user interaction in both enterprise and metaverse contexts. Brelyon is positioned as a pioneer in developing solutions that eliminate the need for headsets, offering a unique viewing experience akin to looking through a large IMAX screen.

Perceptive is focused on the design, development, and manufacturing of medical devices specifically for the dentistry sector. The company has pioneered automated robotics technology that aims to revolutionize dental care by establishing image-guided robotic restorative dentistry as a standard practice. This innovative technology enhances the precision with which dentists can identify and eliminate tooth decay, ultimately delivering superior restorations to patients more efficiently and at a reduced cost. By leveraging advanced techniques, Perceptive enhances clinical capacity and aims to improve overall dental care practices.

Corisma, a spinoff from the Bonde Artificial Heart Lab at Yale University, specializes in developing an innovative circulatory assist device aimed at treating advanced heart failure in Class 3 and Class 4 patients. The company's flagship product, CoRISMA, is a catheter-implanted mechanical circulation system designed to enhance patients' quality of life while minimizing the costs and invasiveness associated with existing therapies. With over $2 million in grant funding, all components of CoRISMA have been prototyped and rigorously tested at Yale, showcasing the commitment to advancing heart failure treatment through cutting-edge technology.

Aegis Life is a biotechnology company focused on advancing nucleic acid delivery technology, specifically through its proprietary platform known as fusogenix PLV. This technology, developed over two decades, is designed to facilitate the rapid development and commercialization of vaccines and therapeutics aimed at preventing and treating infectious diseases. Aegis Life's innovative approach supports the pharmaceutical industry in accelerating the discovery, clinical development, and manufacturing processes for vaccines and treatments, particularly in response to emerging health threats such as COVID-19.

Cornami, Inc. is a high-performance computing company based in Campbell, California, with additional offices in Sacramento and Boston. Founded in 2011, Cornami has developed a patented multi-core technology that enhances software performance, power efficiency, and latency while significantly increasing compute performance. This innovative approach allows processor cores to function as scalable resources, similar to memory and storage, facilitating real-time computing with minimal cost and power consumption. Cornami's technology aims to support a variety of markets, with an initial emphasis on Big Data, by enabling real-time fully homomorphic encryption and providing high-performance computing capabilities across diverse devices and platforms.

Avails Medical, Inc. is an in vitro diagnostics company based in Menlo Park, California, focused on addressing antibiotic resistance and healthcare-associated infections. Founded in 2013, the company has developed an innovative electronic biosensor technology that enables rapid and accurate detection of infections across various bodily fluids. This technology provides real-time information on antibiotic sensitivity and resistance, allowing healthcare providers to optimize treatment at the point of prescription. Avails Medical's flagship product, eQuant, is a compact instrument that integrates a cuvette with an electrical sensor to analyze diluted blood samples. By facilitating diagnostic-guided therapy, the company's platform significantly reduces the time to treatment from days to minutes, thereby transforming the infection detection landscape and addressing a critical global health challenge.

ProteoWise Inc., founded in 2018 and based in Branford, Connecticut, specializes in the development of innovative proteomics instruments. The company has created a unique 3-dimensional nanoscale protein capturing material that significantly enhances the analysis of proteins, enabling researchers to conduct experiments more easily and efficiently. ProteoWise's technology simplifies the traditional western blot method, providing a combination of high information content, high throughput, and low cost. This advancement is instrumental in driving the genomic revolution and supports the growing demands of proteomics research. The company was established by a team of experienced scientists from the Strittmatter Lab at Yale University, who bring a strong history of innovation to the field.

Kiwibot is a pioneer in the development of autonomous robotic systems, specializing in sidewalk delivery robots that operate independently and efficiently. The company focuses on creating a sustainable robotic delivery infrastructure, offering on-demand delivery solutions that include food delivery drones. These robots are designed to reduce delivery costs, allowing businesses to provide faster and more hygienic service to their customers at affordable prices. Kiwibot's innovative approach aims to transform the delivery landscape by leveraging technology to enhance efficiency and convenience in urban environments.

Repurpose, Inc., established in 2011 and headquartered in Los Angeles, California, specializes in the development, manufacturing, and distribution of plant-based, compostable tableware. Their product range includes plates, cups, bowls, and utensils, sold both online and through retail stores across the United States. Repurpose's mission is to provide eco-friendly alternatives to petroleum-based disposable plasticware, contributing to a cleaner environment and promoting sustainable practices among consumers and businesses.

Aperiomics, Inc. is a biotechnology company based in Sterling, Virginia, specializing in pathogen detection services for the animal screening, agricultural testing, and human diagnostics industries. Founded in 2013 and initially known as NextGen Diagnostics, the company changed its name in 2014. Aperiomics utilizes advanced sequencing technologies and a proprietary informatics pipeline to identify a wide range of pathogens, including viral, bacterial, fungal, and parasitic organisms, through a single test. By employing Deep Shotgun Metagenomic Sequencing and leveraging a comprehensive database of over 37,000 microbes, Aperiomics enables medical professionals to identify infections that may be missed by conventional testing methods. This innovative approach has aided many patients suffering from unexplained illnesses by providing accurate diagnoses and facilitating effective treatment pathways. Recognized for its contributions to the field, Aperiomics received accolades such as Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.

MODit 3D Inc., incorporated in 2016 and based in San Rafael, California, specializes in automated quality control solutions for the manufacturing sector. The company offers mass-deployable 3D scanning systems coupled with a cloud platform designed to enhance production yields and improve quality communication throughout the supply chain. By leveraging advanced technology, MODit aims to optimize manufacturing processes and ensure consistent product quality.

Novuson, Inc. is a medical technology company based in Bothell, Washington, specializing in the development of ultrasonic surgical devices. Founded in 2014 as a spinout from the University of Washington’s Applied Physics Laboratory, Novuson focuses on its Direct Therapeutic Ultrasound (DTU) technology platform, which is designed to provide coagulation and hemostatic control during surgical and trauma procedures. The company’s product lineup includes an ultrasonic clamp, a beam ablation/cauterization probe, and a precision beam ultrasonic scalpel, all of which enable clinicians to treat or remove tumors and manage bleeding in solid organs and highly vascularized tissues effectively. By utilizing focused ultrasound energy, Novuson’s devices facilitate rapid hemostasis, cauterization, and division, thereby reducing operational costs and enhancing patient outcomes while minimizing complications related to bleeding.

Tandem PV, Inc. is a manufacturer of advanced photovoltaic cells that combine perovskite and silicon technologies. Originally established as Iris Photovoltaics in 2016, the company rebranded in February 2018 and is headquartered in Palo Alto, California. Tandem PV specializes in mechanically-stacked perovskite and silicon tandem solar panels, which enhance solar panel efficiency significantly. By integrating metal-halide perovskite with existing silicon technology, Tandem PV aims to provide clients with improved performance and reduced installation costs, thereby increasing the overall value and market potential of solar energy.

SkyCool Systems Inc., based in San Francisco, California, specializes in the development and manufacture of innovative cooling and refrigeration systems. Founded in 2016, the company utilizes radiative cooling technology, which involves specially designed optical films that are highly reflective to sunlight and effective at emitting thermal radiation into space. This technology allows their rooftop cooling panels to operate passively during the day, even in high temperatures. SkyCool's systems can serve as add-ons to existing air conditioning and refrigeration setups, and in some cases, can replace traditional air condensing units. By providing sustainable and energy-efficient solutions, SkyCool Systems aims to help customers reduce their energy costs and carbon footprints, contributing to a cleaner and more sustainable future.

Mirada Technologies Inc., established in 2017 and headquartered in San Francisco, specializes in developing and selling LiDAR sensor components. These components are integral to advanced driver safety systems and autonomous vehicles, primarily serving automotive suppliers. Mirada's core offerings include innovative laser scanning and detector technology, with its flagship product being a state-of-the-art laser scanner that ensures accurate ranging distance, wide field of view, reliability, and scalable volume production.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. This technology allows healthcare professionals to detect and monitor blood concentrations, facilitating timely and appropriate therapy for patients requiring critical care in clinical settings. Founded in 2015 and based in El Cerrito, California, ProbiusDx aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

MoQuality Inc., founded in 2014 and headquartered in Atlanta, Georgia, specializes in artificial intelligence-driven mobile testing solutions. The company aims to enhance app quality and improve user experiences by providing tools that simplify and accelerate the testing process. MoQuality's flagship product, Barista, offers a scriptless test-automation experience, leveraging AI to generate user-centric test scenarios that automate testing across various mobile platforms and real devices. This platform allows developers to identify and address issues before releasing their applications, ensuring high-quality performance for both Android and iOS apps. MoQuality is supported by investors including Amity Ventures, Cox Enterprises, and Techstars.

Vartega Inc. specializes in recycling carbon fiber, a material known for its strength and lightweight properties, primarily serving the aerospace, automotive, wind energy, and sporting goods sectors. Founded in 2014 and based in Golden, Colorado, Vartega has developed a patented recycling process that produces low-cost carbon fiber suitable for various applications, including thermoplastic pellets, nonwoven fabrics, yarns, and three-dimensional printing filament. The company’s technology effectively diverts carbon fiber scrap and waste from landfills, contributing to environmental sustainability by reducing greenhouse gas emissions and enhancing fuel economy in vehicles. Vartega's carbon fiber is available in multiple forms, including semi-continuous, chopped, and milled, making it adaptable for mass-market use.

Blumio, Inc. is a San Francisco-based company founded in 2014 that specializes in developing non-invasive wearable sensors for cardiovascular diagnostics, particularly blood pressure monitoring. The company’s innovative technology employs radio frequency to detect and analyze arterial tissue movements, allowing for continuous blood pressure measurement without the need for traditional inflatable cuffs. Blumio aims to address the limitations of conventional blood pressure monitoring methods, which typically rely on measurements taken at rest with a sphygmomanometer. By providing a portable sensor that can be integrated with everyday devices, such as an iPhone case, Blumio enables users to accurately track their blood pressure throughout daily activities, enhancing the understanding of cardiovascular health.

Motion Gestures is a Canadian startup founded in 2016 in Waterloo, specializing in machine learning-based gesture recognition software. The company focuses on developing technology that enables the rapid creation of gesture-enabled interfaces for various systems, devices, and applications. Its software supports advanced 2D and 3D gesture recognition utilizing motion, touch, and vision sensors. This technology can be deployed across different platforms, including cloud, gateway, and embedded systems, allowing for quick integration without the need for extensive programming or data input. Motion Gestures provides developers with free licenses to its cloud SDK, facilitating the swift creation and testing of gestures using smartphones.

Pointcloud is a developer of a 3D imaging platform that utilizes advanced technology for big data analytics on 3D point clouds, leveraging machine learning. The company's innovations are aimed at enhancing applications in augmented reality, robotics, and autonomous mobility, facilitating clearer and more effective visualization of the environment. By focusing on high-performance 4D imaging, Pointcloud positions itself at the forefront of emerging technologies that are set to transform various industries.

InsightFinder Inc. specializes in machine learning technology solutions tailored for information technology operational data. Founded in 2015 and based in Brooklyn, New York, the company offers various tools, including a metric intelligence engine for automatic anomaly detection, a log intelligence engine for real-time keyword extraction, and an alert intelligence engine designed to minimize alert fatigue by suppressing duplicate notifications. Additionally, InsightFinder provides an APM intelligence engine that identifies issues in both proprietary and third-party applications. Utilizing patented unsupervised machine learning algorithms, InsightFinder addresses complex challenges in enterprise AI and IT management, enabling organizations to automatically identify, diagnose, and remediate issues such as model drift and application failures. By focusing on predictive analytics and automated root cause analysis, InsightFinder supports large-scale AI platforms and IT infrastructures in preventing outages and enhancing overall performance.

Landsdowne is a developer focused on innovative battery technology, specifically designed to address the health risks associated with button batteries. The company is commercializing a solution that deactivates batteries after accidental ingestion, aiming to provide a safe alternative for international businesses. Landsdowne's products not only target the growing health crisis related to button batteries but also include materials for injury prevention, ensuring that vulnerable individuals, such as those with fragile skin, are protected. By offering a turnkey, cost-effective solution, Landsdowne seeks to enhance safety and mitigate the risks posed by button batteries in various applications.

Cerahelix, Inc. is a company based in Orono, Maine, that specializes in the design and manufacture of ceramic membrane filters for a variety of applications, including water purification, resource recycling, and biomass processing. Founded in 2011, Cerahelix develops bio-derived products utilizing patented DNA template technology to create sub-nanometer pores in ceramic membranes. This innovative approach allows for the effective filtration of minute particles, enabling the separation of salts, metal ions, and other impurities at the molecular level. The company offers a range of products, including single-channel elements for laboratory and small pilot studies, multi-channel elements for commercial applications, and filter element housings. Additionally, Cerahelix provides laboratory test systems for research and development purposes. Its products serve multiple industries, including food and beverage, mining, pharmaceuticals, and waste-to-energy.

Amperics Inc. is a developer and vendor of advanced energy storage systems, focusing on its proprietary high voltage and high energy density supercapacitor technology. The company offers a range of products, including 12V and 24V modules, capacitors, and various consumer products. Amperics has created an ultra capacitor that matches the energy density of lead acid batteries, positioning itself as a versatile solution provider across multiple applications, such as solar power, consumer electronics, and urban transport. Additionally, the company manufactures emergency battery chargers designed to provide quick power for mobile devices, enabling users to gain significant talk time with minimal charging time. Established in 2009 and headquartered in Livermore, California, Amperics is dedicated to enhancing energy storage capabilities for diverse needs.

Aperio Systems, Inc. specializes in cybersecurity and operational resilience for industrial control systems. Founded in 2020 and headquartered in Boston, Massachusetts, with an additional office in Caesarea, Israel, the company offers proprietary technology that protects against data forgery by detecting artificial manipulation of industrial process data in real-time. This capability ensures accurate monitoring and swift remediation of issues without disrupting operations. Aperio's DataWise platform further enhances data integrity by automatically validating operational data at scale, improving accuracy and security. By providing reliable data, Aperio enables organizations across various sectors to make informed decisions, thereby supporting their profitability and sustainability objectives while effectively managing risks in their industrial operations.

Zenflow, Inc. is a medical device company based in San Francisco, California, that specializes in providing innovative solutions for men suffering from benign prostatic hyperplasia (BPH) symptoms. Founded in 2014 by a team of Stanford University Biodesign Fellows in collaboration with leading urologists, the company aims to address the significant unmet clinical need for effective urinary obstruction treatments. Zenflow's primary product is a spring-like device designed to gently prop open the urethra, restoring its normal function without damaging surrounding tissues. This approach prioritizes patient comfort and minimizes invasiveness, offering a less painful alternative to traditional treatments for urinary obstruction caused by an enlarged prostate.

Okava Pharmaceuticals aims to address the growing veterinary pharmaceutical market by repurposing established human medications for use in treating dogs and cats. The company focuses on developing pet medications that cater to the specific needs of these animals, particularly for managing chronic diseases. By utilizing proven drug delivery technologies, Okava seeks to reduce the high costs and risks typically associated with traditional drug development, thereby enabling pharmaceutical companies to offer more effective treatment options within the veterinary sector. This approach not only capitalizes on an underdeveloped market but also provides a feasible pathway for innovation in animal healthcare.

MODit 3D Inc., incorporated in 2016 and based in San Rafael, California, specializes in automated quality control solutions for the manufacturing sector. The company offers mass-deployable 3D scanning systems coupled with a cloud platform designed to enhance production yields and improve quality communication throughout the supply chain. By leveraging advanced technology, MODit aims to optimize manufacturing processes and ensure consistent product quality.

Riven is a technology company founded in 2017 and headquartered in Berkeley, California, specializing in 3D scanning and software solutions for the manufacturing sector. The company offers proprietary algorithms that enhance manufacturing insights through advanced geometry recognition, automating measurement, inspection, and reporting processes. This innovation addresses critical challenges in New Product Introduction (NPI), a vital stage in manufacturing often plagued by inefficiencies and costly delays. By providing accurate digital 3D copies of physical parts alongside collaborative software tools, Riven simplifies workflows and fosters real-time communication across the supply chain. Their solutions are utilized by manufacturers employing various production methods, including additive manufacturing and injection molding, thereby improving part accuracy, reducing development iterations, and accelerating time-to-market. Riven's focus on creating a digital-first NPI workflow positions it as a key player in transforming manufacturing practices.

BlockApps, Inc. is a blockchain technology company founded in 2015 and based in Brooklyn, New York. It specializes in the development of the BlockApps STRATO platform, which allows enterprises to build, deploy, and manage Ethereum-based blockchain applications. STRATO supports the creation of hybrid private, consortium, and public blockchains, providing a comprehensive solution for various industries, including software startups, IT firms, and Fortune 500 companies. In addition to its core platform, BlockApps has introduced the STRATO Mercata Blockchain Protocol and Marketplace, facilitating the digital ownership of assets like whiskey casks, precious metals, carbon offsets, and collectibles through a network of verified partners. With a focus on enhancing data visibility, automating processes, and reducing reliance on intermediaries, BlockApps aims to enable secure and efficient decentralized application management. The company has garnered approximately $50 million in investments and has established strategic partnerships to further its mission.

C2Sense, Inc. specializes in developing chemiresistive gas sensors and miniaturized sensing technologies aimed at enhancing food quality and safety, particularly in the food and agriculture sectors. Founded in 2013 and based in Cambridge, Massachusetts, the company’s sensors detect gases like ethylene and biogenic amines at low concentrations, allowing stakeholders throughout the supply chain—from growers to consumers—to monitor the freshness of fruits, meats, and other perishable goods, ultimately reducing waste. C2Sense is also advancing its Halo Diagnostics product, a digitally connected immunoassay reader that offers near-PCR sensitivity and facilitates real-time test results through a cloud-based, HIPAA-compliant platform. This technology supports remote healthcare by enabling physicians to access patient test results instantly. Additionally, C2Sense has developed versatile sensing solutions that provide product quality information and counterfeit detection, using safe molecular additives that report on the status of goods throughout the distribution process, thereby enhancing security in various sectors, including pharmaceuticals and luxury goods.

Vivid Vision, Inc. is a company that develops interactive and immersive 3D games aimed at treating vision disorders, particularly amblyopia and strabismus, commonly known as lazy eye and crossed eyes. The company offers a software suite that includes interactive tests for various visual assessments such as eye dominance, suppression, and contrast sensitivity. This suite enables clinicians to monitor and manage patient experiences through a touchscreen interface. By utilizing virtual reality technology, Vivid Vision's system measures eye muscle imbalances and presents tailored images to each eye, facilitating effective treatment and assessment of binocular vision. Founded in 2014 and based in San Francisco, California, Vivid Vision primarily serves eye clinics across North America.

Positron Dynamics, LLC is a technology company based in Port Angeles, Washington, founded in 2011 by Ryan Weed and Joshua Machacek. The company specializes in the development of advanced positron production and storage technologies. It offers semiconductor diagnostic tools designed to detect defects at the atomic level and focuses on applications such as non-destructive testing for aerospace and defense components. Positron Dynamics has developed innovative methods for generating and moderating cold positrons, which are also utilized in propulsion systems aimed at transforming spacecraft operations. The company's propulsion technology harnesses intense beams of cold positrons, potentially enabling the creation of efficient, anti-matter-powered spacecraft for deep space exploration. With several patents awarded for its pioneering technologies, Positron Dynamics is positioned at the forefront of research and development in the field of positron applications.

AquaFresco is transforming the cleaning industry with its innovative wastewater recycling system. Founded by a team that emerged from the MIT MADMEC competition in 2014, the company has advanced its technology from laboratory research to commercial application. Currently, AquaFresco's system is being tested in three pilot hotels and three commercial laundry facilities, with the potential to reduce water and detergent usage by up to 95%. The company holds full ownership of its intellectual property and has gained recognition in the community, winning the MassChallenge Gold Award in 2015 and receiving funding from MassCEC in 2016. AquaFresco is focused on completing product development and pilot testing in the near future.

Synthomics, Inc. specializes in oligonucleotide synthesis solutions, providing advanced RNA and DNA synthesizers that enhance the efficiency and quality of oligonucleotide production. Based in Menlo Park, California, the company develops products for diverse applications, including research, diagnostics, pharmaceuticals, and agriculture. Their innovative synthesizer can accommodate up to 1,536 unique oligonucleotides simultaneously, significantly surpassing the industry standard of 96. This capability not only reduces reagent consumption but also lowers costs and improves turnaround times. Synthomics' flagship "Green Machine" further streamlines DNA synthesis, achieving cost reductions of 20 to 100 times while minimizing waste and enhancing overall quality. Their solutions support critical processes such as next generation sequencing, gene synthesis, gene editing, and PCR, making significant contributions to life sciences innovation.

GraphWear Technologies Inc. is a Philadelphia-based company that specializes in advanced nanotechnology for non-invasive health monitoring. Established in 2015, GraphWear develops a sensing platform that measures vital health indicators, such as glucose and lactic acid levels, from sweat and other bodily fluids. Its innovative patch sensors are designed for real-time monitoring and are particularly beneficial for athletes, enabling them to prevent dehydration and enhance performance. The company is pioneering a no-needle, no-blood approach to health monitoring, which aims to improve the management of chronic diseases like diabetes while also exploring potential applications for heart disease and cancer. Currently, GraphWear is conducting clinical trials to validate its glucose monitoring technology, emphasizing its commitment to providing accessible and accurate health information.

Avitus Orthopaedics, Inc. is a medical device company focused on developing and commercializing minimally invasive surgical devices specifically for autologous bone graft harvesting. The company’s flagship product, the Avitus bone harvester, is designed to efficiently harvest cancellous bone and marrow, aimed at enhancing clinical outcomes in orthopedic surgeries. Founded in 2011 and initially known as BOSS Medical, Inc., the company rebranded to Avitus Orthopaedics in March 2014. With its headquarters in Shelton, Connecticut, Avitus Orthopaedics combines technical expertise and clinical experience to create innovative instruments that not only improve surgical techniques but also aim to reduce healthcare costs for patients.

Immusoft Corporation is a biotechnology company focused on developing an autologous cell therapy platform aimed at treating a range of human diseases through its proprietary Immune System Programming (ISP) technology. Founded in 2009 and based in Seattle, Washington, Immusoft specializes in modifying the DNA of a patient's immune cells to create biofactories capable of producing gene-encoded medicines, including essential proteins and enzymes that may be missing or defective. The company's innovative approach involves reprogramming B cells, a type of immune cell, which enables them to manufacture and secrete various antibodies. This process not only provides a potential long-term solution for patients but also positions Immusoft at the forefront of biotechnology in addressing rare and infectious diseases.

Abtum specializes in developing innovative radio frequency (RF) filter technology, which is essential for enhancing the performance of wireless devices. As the demand for connectivity and bandwidth continues to increase, the need for high-performance RF filters has grown significantly. Abtum's RF chipsets and modules are designed to meet these industry requirements, improving the functionality of filters used in mobile devices, wireless networks, and Internet of Things (IoT) applications. The company's focus on disruptive technology positions it to capitalize on the expanding market for advanced RF solutions, thereby creating substantial business opportunities.

Ligandal Inc. is a biotechnology company based in Oakland, California, focused on developing therapeutic nanotechnologies for precision medicine. Founded in 2013 and originally named Ligandal Technology LLC, the company specializes in creating a delivery platform aimed at curing and treating diseases through advanced gene therapies. Ligandal's technology utilizes a ligand discovery engine to design materials that can transport a variety of nucleic acids and proteins, including CRISPR and mRNA, to specific cell types with high accuracy. Their innovative approach incorporates peptide-based technologies for gene therapy, gene editing, regenerative medicine, and immunotherapy. Ligandal's initial applications of its technology target areas such as hematology, immuno-oncology, and infectious diseases, facilitating precise delivery of genetic materials and improving therapeutic outcomes.

Axiom Exergy Inc. is an energy storage company focused on developing innovative refrigeration batteries designed for supermarkets, cold-storage facilities, and food processors. Founded in 2014 and headquartered in Richmond, California, the company provides energy management solutions that include thermal energy storage retrofits and software for monitoring and managing energy use in refrigeration systems. Its products feature an optional integrated backup cooling system, which safeguards food from spoilage during power outages. Axiom Exergy also offers services related to energy management, thermal energy systems engineering, and hardware development, aiming to optimize energy consumption and reduce operational costs for commercial buildings with significant thermal loads.

CellSight Technologies, Inc. specializes in the development of positron emission tomography (PET) tracers aimed at enhancing the monitoring and effectiveness of immune-oncological therapies. Based in San Francisco, California, the company focuses on its lead PET tracer, VisAcT, which is designed to visualize activated T cells, a crucial component of the immune response in cancer treatment. VisAcT is a Fluorine 18 labeled analog of an FDA-approved drug and can be utilized across various immunotherapy regimens, including adoptive cell therapy, checkpoint inhibitors, and cancer vaccines. Currently undergoing clinical trials at the University of California, San Francisco, VisAcT provides oncologists with valuable imaging tools to assess a patient's immune system response early in the treatment cycle, ultimately aiming to enhance the efficacy of immunotherapy for cancer patients.

TranscribeMe Inc. specializes in audio transcription solutions, providing a platform that converts audio and video into searchable and shareable text. Founded in 2011, the company offers a range of services including speech-to-text conversion, speaker identification, time coding, and keyword analysis. Its technology employs proprietary micro-tasking to handle complex audio with multiple speakers and overlapping conversations, ensuring accurate transcriptions. TranscribeMe caters to various sectors, including medical, market research, conferences, writing, podcasting, and education, enabling clients to analyze, share, and monetize their audio content through precise transcriptions. The company is headquartered in San Francisco, California.

zPREDICTA specializes in bio-simulation technology that integrates biology, automation, and computation to streamline drug development processes. The company offers an organ-specific platform that reconstructs human tissue microenvironments, particularly focusing on the human bone marrow. Its innovative r-Organ technology creates advanced 3D culture models that accurately replicate organ-specific conditions, allowing for precise predictions of drug responses. By utilizing these models, zPREDICTA enables pharmaceutical companies to efficiently identify promising drug candidates, enhancing the likelihood of successful therapeutic outcomes in patients. The company’s approach significantly contributes to the advancement of drug development by improving the understanding of cellular behavior in reaction to anticancer therapies.

Alievio, Inc. is an innovative medical device company based in Research Triangle Park, North Carolina, focused on developing solutions for glaucoma patients. The company has introduced Sollevio, a novel noninvasive device designed for the titration of postoperative intraocular pressure in individuals with refractory glaucoma. This device aims to address the complications commonly associated with traditional glaucoma surgeries and offers ophthalmologists a new tool to halt the progression of the disease. Founded in 2010 and originally known as Camras Vision, Inc., Alievio rebranded in June 2019 to reflect its commitment to advancing glaucoma treatment.

Modal is a developer of digital commerce solutions focused on enhancing the auto-buying experience for dealerships, banks, and automotive brands in the United States. Its platform integrates seamlessly into existing dealership websites and showrooms, allowing for transparent digital transactions. Modal's offerings include a transaction layer that enhances user interactions, Checkout for digital transactions, a connected sales tool called Shop, and a trade tool that supports the buying journey. By simplifying the complexities of auto transactions, Modal aims to elevate customer satisfaction and drive higher sales volumes for automotive retailers. Founded in 2015 and based in San Francisco, the company is backed by prominent investors and comprises a team with experience from leading technology firms.

Neocis, Inc. is a Miami-based company that specializes in robotic guidance systems for dental implant procedures. Founded in 2009, Neocis develops the Yomi system, a robotic device designed to enhance the precision of dental surgeries. Yomi integrates computer imagery from CT scans with surgical planning, providing dental surgeons with multi-sensory feedback during procedures. This technology aims to transform dental surgery by offering a minimally invasive approach, which can lead to faster recovery times for patients. The Yomi system has received clearance from the U.S. Food and Drug Administration and is commercially available in the United States, underscoring Neocis's commitment to advancing patient care and addressing the challenges faced by dental professionals.

Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, founded in 2009. The company specializes in providing customized hydrographic surveys and operates low-cost, self-powered ocean surface drones that form an intelligent sensor network for data collection. Its robotic sailboats, which harness wind and solar energy, are designed for autonomous operation on long-duration missions across vast geographic areas. This technology allows clients in sectors such as defense, energy, shipping, fishing, and research to efficiently gather marine data while minimizing risks to human life and reducing the operational costs associated with traditional vessels in challenging marine environments.

ZelosDx specializes in the development of blood testing products aimed at advancing research in brain health and diseases. The company provides researchers with access to proprietary technology that can be licensed and adapted for blood testing kits and automated laboratory equipment. Additionally, it offers pharmaceutical collaborators biomarker technology to support drug discovery efforts. By delivering critical data for diagnosis, monitoring, and evaluating therapeutic responses, ZelosDx facilitates significant advancements in the understanding and treatment of brain-related conditions.

Evolute specializes in operational management software that enhances container networking and security processes for IT departments. Its technology allows Fortune 500 IT Managers to efficiently migrate applications to containerized environments in under three minutes, achieving significant improvements in compute efficiency and provisioning speed compared to traditional cloud setups. By facilitating reliable migration and management of software applications across various computing environments, Evolute enables organizations to optimize their IT operations while maintaining high security standards. This innovation supports a multi-tenancy network, making it accessible to diverse industries and streamlining container deployment and management in production environments.

IntelliVision Corp. specializes in intelligent video analytics and automated surveillance solutions, developing advanced technologies for video content analysis. The company offers a range of products, including an Intelligent Video solution that automates video monitoring and a Recognition Suite that provides recognition capabilities for faces, objects, and license plates. IntelliVision's software processes and analyzes video data from both analog and digital sources, extracting actionable insights and real-time alerts for various applications, including security, traffic management, and retail analytics. Established in 2003 and headquartered in San Jose, California, IntelliVision also operates offices in Asia and Europe. The company holds patents for its innovative technology, which is recognized for transforming video surveillance through deep learning and artificial intelligence. As of 2018, IntelliVision operates as a subsidiary of Nortek Security & Control, LLC.

Aromyx Corporation is a biotechnology company that has developed a platform for the digital capture of taste and scent, enabling quantitative representations of sensory data. The company's core product, the EssenceChip, utilizes a disposable bioassay to replicate human olfactory and taste receptors, providing a digital readout of biochemical signals from various substances. This technology is particularly useful for predicting the scent of new chemicals and is employed across multiple industries, including consumer packaged goods, food and beverage, tobacco, and flavor and fragrance. Aromyx also offers a suite of software tools, such as Allegory and AromaGraph, which facilitate the analysis, modification, and archiving of sensory data. Founded in 2006 and based in Mountain View, California, Aromyx aims to enhance product development, quality assurance, and branding through its innovative approach to sensory analysis.

Bounce Imaging, Inc. specializes in the manufacturing of tactical throwable cameras equipped with multiple lenses and sensors, designed primarily for use by police and firefighters. The company's innovative products enable first responders to safely assess hazardous environments remotely, providing real-time video and sensor data while maintaining stability during movement. In addition to its camera systems, Bounce Imaging offers a variety of accessories, including pole attachments, tethers, car chargers, headsets, wrist straps, and magnetic mounts. The company also provides cloud-based services that encompass technical consulting, design and implementation support, and troubleshooting for imaging and processing hardware. Founded in 2012, Bounce Imaging is headquartered in Buffalo, New York.

NGX Bio is an online marketplace that facilitates access to DNA sequencing services, connecting researchers with high-quality genomic resources. By streamlining the sequencing process, the platform allows customers to complete their projects in a single transaction, ensuring cost-effectiveness through partnerships with providers that have available capacity. NGX Bio offers a comprehensive range of services, including design and planning, sample preparation, sequencing, and data analysis. Additionally, the company features an online project management tool that enhances sample tracking through the use of barcoded tubes and plates. Serving a global clientele, NGX Bio simplifies the sequencing experience for researchers worldwide.

Agralogics Inc. is a data platform provider based in Walnut Creek, California, focused on enhancing the operational efficiency of Food and Water Enterprises. Established in 2013, the company facilitates in-field collaboration, regulatory compliance, and resource conservation through its innovative platform. Agralogics simplifies the processes of growing, processing, and selling food by enabling users to easily access both public and private data. The platform offers intuitive data visualization and actionable intelligence, allowing clients to analyze, organize, and collaborate effectively using data-driven insights. Additionally, it provides predictive analytics capabilities to support informed decision-making within the food ecosystem.

Neurogastrx, Inc. is a venture-stage biopharmaceutical company focused on developing innovative therapies for gastrointestinal disorders. Established in 2017 and located in Campbell, California, the company aims to address the unmet medical needs associated with functional and motility disorders of the gastrointestinal tract. One of its key products, NG101, is designed to enhance gastric motility while also possessing antiemetic properties. Neurogastrx's specialty therapies target the enteric nervous system, addressing issues related to gut contractions, sensation, and the brain-gut axis, ultimately striving to alleviate the burden of these disorders on patients and the healthcare system.